A first-gneration subunit vaccine for East Coast fever based on the Theileria parva p67 sporozoite surface antigen is entering preliminary field trials. Intensive efforts are also focused on the identification of a schizont-specific omponen for incorporation in a second-generation multi-component...
Enlace original:
https://cgspace.cgiar.org/handle/10568/32963
McKeever, Declan J.
,
Morrison, W. Ivan
,
[Invited review Novel vaccines against Theileria parva: prospects for sustainability]
,
Invited review Novel vaccines against Theileria parva: prospects for sustainability